PharVision Advisers’s Zeta Global ZETA Stock Holding History

PharVision Advisers’s Portfolio ZETA Stock Details ZETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,835	Closed	-$199K	–	820
2025 Q2	$199K	Buy	+12,835	New	+$170K	0.29%	206

Other funds holding ZETA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return

Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PharVision Advisers's ZETA Position: Q3 2025 in Review

PharVision Advisers sold out of Zeta Global (ZETA) in Q3 2025, closing a stake of 12,835 shares — an estimated $199K sold.

PharVision Advisers first reported a position in ZETA in Q2 2025 and held it in 1 quarter. The position peaked at $199K in Q2 2025. 358 funds tracked by Wall St. Rank hold ZETA as of Q3 2025.

PharVision Advisers reported no remaining Zeta Global position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 12,835 Zeta Global shares in Q3 2025, an estimated $199K.
PharVision Advisers first reported a position in Zeta Global in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Zeta Global position peaked at $199K in Q2 2025.
358 funds tracked by Wall St. Rank held Zeta Global as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.